Interactive Investor
>>

Poxel SA (EURONEXT:POXEL) Share Price

POXEL

Poxel SA

European company

Right Arrow 1

Healthcare

Right Arrow 2

Biotechnology

 / 

- / -
-
- / -
-
-
-

Bid

-

Ask

-

Last Traded

-

Chg

-

-

XPAR

-

Updated: -

Research

News & analysis

Loading...

Times are shown in GMT+2, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

Poxel SA is a biopharmaceutical company. It is focused on the development of novel treatments for metabolic diseases, including type 2 diabetes and liver diseases, such as nonalcoholic steatohepatitis (NASH). It has developed a portfolio of drug candidates, including its three most advanced candidates: Imeglimin, for the treatment of type 2 diabetes, and PXL770 and PXL065, for the treatment of NASH.Poxel SA is a biopharmaceutical company. It is developing drugs for metabolic diseases, in particular Type 2 diabetes.

EURONEXT:POXEL

FR0012432516

EUR

Loading...

Loading Comparison

Latest POXEL News